Young Richard A
Insider CIK 1490283 · SYRS Director · CAMP Director · OMGA Director · ENZN Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| CAMP Camp4 Therapeutics Corp | P Buy | 2026-08-03 | 2026-08-05 | 16,378 | $1.65 | $27.0K | 186,388 | SEC↗ |
| CAMP Camp4 Therapeutics Corp | P Buy | 2026-08-03 | 2026-08-05 | 16,378 | $1.65 | $27.0K | 186,388 | SEC↗ |
| CAMP Camp4 Therapeutics Corp | A Award deriv | 2026-06-10 | 2026-06-12 | 28,000 | — | $0 | 28,000 | SEC↗ |
| CAMP Camp4 Therapeutics Corp | P Buy | 2025-09-11 | 2025-09-11 | 15,151 | $1.65 | $25.0K | 170,010 | SEC↗ |
| CAMP Camp4 Therapeutics Corp | A Award deriv | 2025-06-25 | 2025-06-27 | 9,000 | — | $0 | 9,000 | SEC↗ |
| CAMP Camp4 Therapeutics Corp | C Conversion deriv | 2024-10-15 | 2024-10-15 | 100,014 | — | $0 | 0 | SEC↗ |
| CAMP Camp4 Therapeutics Corp | C Conversion | 2024-10-15 | 2024-10-15 | 8,917 | — | $0 | 154,859 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | M Exercise deriv | 2024-09-16 | 2024-09-18 | 2,667 | — | $0 | 2,667 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | M Exercise | 2024-09-16 | 2024-09-18 | 2,667 | — | $0 | 10,667 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | S Sale | 2024-06-28 | 2024-07-02 | 34,837 | $5.12 | $178.4K | 8,000 | SEC↗ |
| OMGA Omega Therapeutics, Inc. | A Award deriv | 2024-06-20 | 2024-06-21 | 25,000 | — | $0 | 25,000 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | A Award deriv | 2024-06-05 | 2024-06-07 | 6,000 | — | $0 | 6,000 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | A Award | 2024-06-05 | 2024-06-07 | 4,000 | — | $0 | 42,837 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | M Exercise deriv | 2023-09-16 | 2023-09-19 | 2,666 | — | $0 | 5,334 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | M Exercise | 2023-09-16 | 2023-09-19 | 2,666 | — | $0 | 38,837 | SEC↗ |
| OMGA Omega Therapeutics, Inc. | A Award deriv | 2023-06-07 | 2023-06-09 | 18,118 | — | $0 | 18,118 | SEC↗ |
| OMGA Omega Therapeutics, Inc. | S Sale | 2023-06-02 | 2023-06-05 | 5,000 | $8.00 | $40.0K | 739,118 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | A Award deriv | 2023-06-01 | 2023-06-02 | 6,000 | — | $0 | 6,000 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | A Award | 2023-06-01 | 2023-06-02 | 4,000 | — | $0 | 36,171 | SEC↗ |
| OMGA Omega Therapeutics, Inc. | S Sale | 2023-05-01 | 2023-05-03 | 5,000 | $8.00 | $40.0K | 744,118 | SEC↗ |
| OMGA Omega Therapeutics, Inc. | S Sale | 2023-04-06 | 2023-04-10 | 5,000 | $8.00 | $40.0K | 749,118 | SEC↗ |
| OMGA Omega Therapeutics, Inc. | S Sale | 2023-03-17 | 2023-03-20 | 10,000 | $8.00 | $80.0K | 754,118 | SEC↗ |
| OMGA Omega Therapeutics, Inc. | S Sale | 2023-01-10 | 2023-01-11 | 20,000 | $8.00 | $160.0K | 764,118 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | A Award deriv | 2022-09-16 | 2022-09-19 | 12,000 | — | $0 | 12,000 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | A Award deriv | 2022-09-16 | 2022-09-19 | 8,000 | — | $0 | 8,000 | SEC↗ |
| OMGA Omega Therapeutics, Inc. | S Sale | 2022-09-14 | 2022-09-15 | 10,000 | $8.00 | $80.0K | 784,118 | SEC↗ |
| OMGA Omega Therapeutics, Inc. | A Award deriv | 2022-06-08 | 2022-06-10 | 18,118 | — | $0 | 18,118 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | A Award deriv | 2022-06-01 | 2022-06-02 | 17,500 | — | $0 | 17,500 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | A Award deriv | 2021-06-08 | 2021-06-10 | 17,500 | — | $0 | 17,500 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | S Sale | 2021-02-16 | 2021-02-18 | 3,750 | $12.05 | $45.2K | 321,711 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | S Sale | 2021-02-08 | 2021-02-10 | 3,750 | $13.04 | $48.9K | 325,461 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | S Sale | 2020-11-17 | 2021-02-10 | 5,357 | $8.75 | $46.9K | 329,211 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | S Sale | 2020-11-17 | 2020-11-18 | 5,357 | $8.75 | $46.9K | 339,211 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | S Sale | 2020-11-16 | 2021-02-10 | 633 | $8.98 | $5.7K | 334,568 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | S Sale | 2020-11-16 | 2020-11-18 | 633 | $8.98 | $5.7K | 344,568 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | S Sale | 2020-10-19 | 2020-10-19 | 5,673 | $8.75 | $49.6K | 335,201 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | S Sale | 2020-10-15 | 2020-10-16 | 317 | $8.75 | $2.8K | 340,874 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | S Sale | 2020-09-15 | 2020-09-16 | 5,990 | $10.39 | $62.2K | 341,191 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | S Sale | 2020-08-17 | 2020-08-19 | 5,990 | $12.59 | $75.4K | 347,181 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | S Sale | 2020-07-15 | 2020-07-17 | 5,990 | $11.85 | $71.0K | 353,171 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | S Sale | 2020-06-15 | 2020-06-16 | 5,990 | $8.75 | $52.4K | 359,161 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | A Award deriv | 2020-06-11 | 2020-06-11 | 17,500 | — | $0 | 17,500 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | S Sale | 2020-05-15 | 2020-05-15 | 5,990 | $9.22 | $55.2K | 365,151 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | S Sale | 2020-04-15 | 2020-04-17 | 23,960 | $8.75 | $209.7K | 371,141 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | S Sale | 2019-08-16 | 2019-08-19 | 22,700 | $10.00 | $227.0K | 395,101 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | S Sale | 2019-08-15 | 2019-08-19 | 2,300 | $10.00 | $23.0K | 417,801 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | A Award deriv | 2019-06-11 | 2019-06-12 | 11,000 | — | $0 | 11,000 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | A Award deriv | 2018-06-14 | 2018-06-15 | 11,000 | — | $0 | 11,000 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | S Sale | 2017-08-14 | 2017-08-16 | 3,282 | $22.00 | $72.2K | 420,101 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | S Sale | 2017-07-25 | 2017-07-27 | 3,282 | $22.09 | $72.5K | 423,383 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | A Award deriv | 2017-06-08 | 2017-09-22 | 11,000 | — | $0 | 11,000 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | A Award deriv | 2017-06-08 | 2017-06-12 | 11,000 | — | $0 | 11,000 | SEC↗ |
| SYRS Syros Pharmaceuticals, Inc | A Award deriv | 2016-09-15 | 2016-09-19 | 22,000 | — | $0 | 22,000 | SEC↗ |
| ENZN ENZON PHARMACEUTICALS INC | A Award deriv | 2013-01-02 | 2013-01-04 | 20,129 | — | $0 | 20,129 | SEC↗ |
| ENZN ENZON PHARMACEUTICALS INC | A Award | 2012-07-02 | 2012-07-03 | 10,669 | — | $0 | 30,231 | SEC↗ |
| ENZN ENZON PHARMACEUTICALS INC | S Sale | 2012-03-15 | 2012-03-16 | 2,000 | $6.92 | $13.8K | 19,562 | SEC↗ |
| ENZN ENZON PHARMACEUTICALS INC | A Award deriv | 2012-01-03 | 2012-01-05 | 10,994 | — | $0 | 10,994 | SEC↗ |